Tissue plasminogen activator can effectively declot peritoneal dialysis catheters [1]

American Journal of Kidney Diseases

Volumn 36, Issue 3, 2000, Pages 675-

  Sahani, M M ^a   Mukhtar, K N ^a   Boorgu, R ^a   Leehey, D J ^a   Popli, S ^a   Ing, T S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

CENTRAL VENOUS CATHETER; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG POTENCY; FIBRIN CLOT; FIBRIN DEPOSITION; LETTER; NONHUMAN; OCCLUSION; PERITONEAL DIALYSIS; TUBE FLOW;

EID: 0033864369     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.16212     Document Type: Article

References (3)

1. A hemostasis study in CAPD patients during fibrinolytic intraperitoneal therapy with urokinase (UK)
2. Use of tissue plasminogen activator for reopening of clotted dialysis catheters
3. Bioactivity of cryopreserved alteplase solutions